Compile Data Set for Download or QSAR
maximum 50k data
Found 78 Enz. Inhib. hit(s) with all data for entry = 9041
TargetBeta-2 adrenergic receptor(Homo sapiens (Human))
The Usa, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM50213115((R,R)-(-)-5-{1-hydroxy-2-[1-methyl-2-(1-naphthyl)e...)
Affinity DataKi:  2.41E+5nMAssay Description:HEK 293 cells stability transfected with cDNA encoding human β2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBeta-2 adrenergic receptor(Homo sapiens (Human))
The Usa, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM50213110((R,S)-(-)-5-{1-hydroxy-2-[1-methyl-2-(1-naphthyl)e...)
Affinity DataKi:  3.41E+5nMAssay Description:HEK 293 cells stability transfected with cDNA encoding human β2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBeta-2 adrenergic receptor(Homo sapiens (Human))
The Usa, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM50213098((R,R)-(-)-fenoterol | CHEMBL388570 | US10617654, C...)
Affinity DataKi:  3.45E+5nMAssay Description:HEK 293 cells stability transfected with cDNA encoding human β2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBeta-2 adrenergic receptor(Homo sapiens (Human))
The Usa, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM50213099((R,R)-(-)-1-p-methoxyphenyl-2-(beta-3',5'-dihydrox...)
Affinity DataKi:  4.74E+5nMAssay Description:HEK 293 cells stability transfected with cDNA encoding human β2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBeta-2 adrenergic receptor(Homo sapiens (Human))
The Usa, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM50213096((S,R)-(+)-5-{1-hydroxy-2-[1-methyl-2-(1-naphthyl)e...)
Affinity DataKi:  1.78E+6nMAssay Description:HEK 293 cells stability transfected with cDNA encoding human β2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBeta-2 adrenergic receptor(Homo sapiens (Human))
The Usa, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM50213117((R,R)-(-)-5-[1-hydroxy-2-(1-methyl-2-phenylethylam...)
Affinity DataKi:  1.86E+6nMAssay Description:HEK 293 cells stability transfected with cDNA encoding human β2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBeta-2 adrenergic receptor(Homo sapiens (Human))
The Usa, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM50213120((R,S)-(-)-1-p-methoxyphenyl-2-(beta-3',5'-dihydrox...)
Affinity DataKi:  1.93E+6nMAssay Description:HEK 293 cells stability transfected with cDNA encoding human β2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBeta-2 adrenergic receptor(Homo sapiens (Human))
The Usa, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM50213101((S,S)-(+)-5-{1-hydroxy-2-[1-methyl-2-(1-naphthyl)e...)
Affinity DataKi:  2.54E+6nMAssay Description:HEK 293 cells stability transfected with cDNA encoding human β2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBeta-2 adrenergic receptor(Homo sapiens (Human))
The Usa, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM50213108((R,R)-(-)-5-{2-[2-(4-aminophenyl)-1-methylethylami...)
Affinity DataKi:  2.93E+6nMAssay Description:HEK 293 cells stability transfected with cDNA encoding human β2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBeta-1 adrenergic receptor(Mus musculus)
The Usa, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM50213115((R,R)-(-)-5-{1-hydroxy-2-[1-methyl-2-(1-naphthyl)e...)
Affinity DataKi:  3.35E+6nMAssay Description:β1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBeta-2 adrenergic receptor(Homo sapiens (Human))
The Usa, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM50213106((R,S)-(-)-fenoterol | CHEMBL229476 | US10617654, C...)
Affinity DataKi:  3.70E+6nMAssay Description:HEK 293 cells stability transfected with cDNA encoding human β2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBeta-2 adrenergic receptor(Homo sapiens (Human))
The Usa, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM50213097((S,R)-(+)-1-p-methoxyphenyl-2-(beta-3',5'-dihydrox...)
Affinity DataKi:  5.27E+6nMAssay Description:HEK 293 cells stability transfected with cDNA encoding human β2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBeta-2 adrenergic receptor(Homo sapiens (Human))
The Usa, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM50213111((R,S)-(-)-5-[1-hydroxy-2-(1-methyl-2-phenylethylam...)
Affinity DataKi:  6.04E+6nMAssay Description:HEK 293 cells stability transfected with cDNA encoding human β2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBeta-2 adrenergic receptor(Homo sapiens (Human))
The Usa, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM50213112((R,S)-(-)-5-{2-[2-(4-aminophenyl)-1-methylethylami...)
Affinity DataKi:  7.94E+6nMAssay Description:HEK 293 cells stability transfected with cDNA encoding human β2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBeta-2 adrenergic receptor(Homo sapiens (Human))
The Usa, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM50213107((R,R)-(-)-5-[1-hydroxy-2-(1-methylhexylamino)ethyl...)
Affinity DataKi:  9.28E+6nMAssay Description:HEK 293 cells stability transfected with cDNA encoding human β2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBeta-1 adrenergic receptor(Mus musculus)
The Usa, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM50213107((R,R)-(-)-5-[1-hydroxy-2-(1-methylhexylamino)ethyl...)
Affinity DataKi:  1.02E+7nMAssay Description:β1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBeta-2 adrenergic receptor(Homo sapiens (Human))
The Usa, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM50213103((S,R)-(+)-fenoterol | CHEMBL229477 | US10617654, C...)
Affinity DataKi:  1.03E+7nMAssay Description:HEK 293 cells stability transfected with cDNA encoding human β2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBeta-2 adrenergic receptor(Homo sapiens (Human))
The Usa, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM50213119((R)-(-)-5-(1-hydroxy-2-phenethylaminoethyl)-1,3-be...)
Affinity DataKi:  1.05E+7nMAssay Description:HEK 293 cells stability transfected with cDNA encoding human β2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBeta-1 adrenergic receptor(Mus musculus)
The Usa, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM50213098((R,R)-(-)-fenoterol | CHEMBL388570 | US10617654, C...)
Affinity DataKi:  1.48E+7nMAssay Description:β1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBeta-1 adrenergic receptor(Mus musculus)
The Usa, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM50213110((R,S)-(-)-5-{1-hydroxy-2-[1-methyl-2-(1-naphthyl)e...)
Affinity DataKi:  1.58E+7nMAssay Description:β1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBeta-2 adrenergic receptor(Homo sapiens (Human))
The Usa, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM50213102((S,S)-(+)-1-p-methoxyphenyl-2-(beta-3',5'-dihydrox...)
Affinity DataKi:  1.59E+7nMAssay Description:HEK 293 cells stability transfected with cDNA encoding human β2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBeta-1 adrenergic receptor(Mus musculus)
The Usa, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM50213117((R,R)-(-)-5-[1-hydroxy-2-(1-methyl-2-phenylethylam...)
Affinity DataKi:  1.72E+7nMAssay Description:β1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBeta-1 adrenergic receptor(Mus musculus)
The Usa, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM50213106((R,S)-(-)-fenoterol | CHEMBL229476 | US10617654, C...)
Affinity DataKi:  1.89E+7nMAssay Description:β1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBeta-2 adrenergic receptor(Homo sapiens (Human))
The Usa, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM50213121((S)-(+)-5-(1-hydroxy-2-phenethylaminoethyl)-1,3-be...)
Affinity DataKi:  2.06E+7nMAssay Description:HEK 293 cells stability transfected with cDNA encoding human β2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBeta-1 adrenergic receptor(Mus musculus)
The Usa, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM50213099((R,R)-(-)-1-p-methoxyphenyl-2-(beta-3',5'-dihydrox...)
Affinity DataKi:  2.20E+7nMAssay Description:β1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBeta-2 adrenergic receptor(Homo sapiens (Human))
The Usa, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM50213116((S,R)-(+)-5-{2-[2-(4-aminophenyl)-1-methylethylami...)
Affinity DataKi:  2.31E+7nMAssay Description:HEK 293 cells stability transfected with cDNA encoding human β2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBeta-1 adrenergic receptor(Mus musculus)
The Usa, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM50213108((R,R)-(-)-5-{2-[2-(4-aminophenyl)-1-methylethylami...)
Affinity DataKi:  2.50E+7nMAssay Description:β1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBeta-2 adrenergic receptor(Homo sapiens (Human))
The Usa, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM50213114((S,S)-(+)-fenoterol | CHEMBL389390 | US10617654, C...)
Affinity DataKi:  2.77E+7nMAssay Description:HEK 293 cells stability transfected with cDNA encoding human β2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBeta-2 adrenergic receptor(Homo sapiens (Human))
The Usa, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM50213118((S,S)-(+)-5-{2-[2-(4-aminophenyl)-1-methylethylami...)
Affinity DataKi:  2.86E+7nMAssay Description:HEK 293 cells stability transfected with cDNA encoding human β2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBeta-2 adrenergic receptor(Homo sapiens (Human))
The Usa, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM50213104((S,S)-(+)-5-[1-hydroxy-2-(1-methyl-2-phenylethylam...)
Affinity DataKi:  2.87E+7nMAssay Description:HEK 293 cells stability transfected with cDNA encoding human β2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBeta-1 adrenergic receptor(Mus musculus)
The Usa, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM50213120((R,S)-(-)-1-p-methoxyphenyl-2-(beta-3',5'-dihydrox...)
Affinity DataKi:  3.07E+7nMAssay Description:β1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBeta-2 adrenergic receptor(Homo sapiens (Human))
The Usa, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM50213100((S,R)-(+)-5-[1-hydroxy-2-(1-methyl-2-phenylethylam...)
Affinity DataKi:  3.08E+7nMAssay Description:HEK 293 cells stability transfected with cDNA encoding human β2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBeta-1 adrenergic receptor(Mus musculus)
The Usa, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM50213112((R,S)-(-)-5-{2-[2-(4-aminophenyl)-1-methylethylami...)
Affinity DataKi:  3.13E+7nMAssay Description:β1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBeta-2 adrenergic receptor(Homo sapiens (Human))
The Usa, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM50213109((R,S)-(-)-5-[1-hydroxy-2-(1-methylhexylamino)ethyl...)
Affinity DataKi:  3.14E+7nMAssay Description:HEK 293 cells stability transfected with cDNA encoding human β2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBeta-1 adrenergic receptor(Mus musculus)
The Usa, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM50213118((S,S)-(+)-5-{2-[2-(4-aminophenyl)-1-methylethylami...)
Affinity DataKi:  3.14E+7nMAssay Description:β1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBeta-1 adrenergic receptor(Mus musculus)
The Usa, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM50213111((R,S)-(-)-5-[1-hydroxy-2-(1-methyl-2-phenylethylam...)
Affinity DataKi:  3.30E+7nMAssay Description:β1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBeta-1 adrenergic receptor(Mus musculus)
The Usa, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM50213097((S,R)-(+)-1-p-methoxyphenyl-2-(beta-3',5'-dihydrox...)
Affinity DataKi:  3.34E+7nMAssay Description:β1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBeta-1 adrenergic receptor(Mus musculus)
The Usa, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM50213096((S,R)-(+)-5-{1-hydroxy-2-[1-methyl-2-(1-naphthyl)e...)
Affinity DataKi:  3.47E+7nMAssay Description:β1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBeta-1 adrenergic receptor(Mus musculus)
The Usa, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM50213119((R)-(-)-5-(1-hydroxy-2-phenethylaminoethyl)-1,3-be...)
Affinity DataKi:  4.25E+7nMAssay Description:β1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBeta-1 adrenergic receptor(Mus musculus)
The Usa, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM50213121((S)-(+)-5-(1-hydroxy-2-phenethylaminoethyl)-1,3-be...)
Affinity DataKi:  5.22E+7nMAssay Description:β1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBeta-1 adrenergic receptor(Mus musculus)
The Usa, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM50213105((S,S)-(+)-5-[1-hydroxy-2-(1-methylhexylamino)ethyl...)
Affinity DataKi:  5.26E+7nMAssay Description:β1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBeta-2 adrenergic receptor(Homo sapiens (Human))
The Usa, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM50213105((S,S)-(+)-5-[1-hydroxy-2-(1-methylhexylamino)ethyl...)
Affinity DataKi:  5.64E+7nMAssay Description:HEK 293 cells stability transfected with cDNA encoding human β2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBeta-1 adrenergic receptor(Mus musculus)
The Usa, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM50213113((S,R)-(+)-5-[1-hydroxy-2-(1-methylhexylamino)ethyl...)
Affinity DataKi:  6.13E+7nMAssay Description:β1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBeta-1 adrenergic receptor(Mus musculus)
The Usa, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM50213116((S,R)-(+)-5-{2-[2-(4-aminophenyl)-1-methylethylami...)
Affinity DataKi:  7.75E+7nMAssay Description:β1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBeta-2 adrenergic receptor(Homo sapiens (Human))
The Usa, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM50213113((S,R)-(+)-5-[1-hydroxy-2-(1-methylhexylamino)ethyl...)
Affinity DataKi: >1.00E+8nMAssay Description:HEK 293 cells stability transfected with cDNA encoding human β2-AR (provided by Dr. Brian Kobilka, Stanford Medical Center, Palo Alto, Calif.) w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBeta-1 adrenergic receptor(Mus musculus)
The Usa, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM50213109((R,S)-(-)-5-[1-hydroxy-2-(1-methylhexylamino)ethyl...)
Affinity DataKi: >1.00E+8nMAssay Description:β1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBeta-1 adrenergic receptor(Mus musculus)
The Usa, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM50213101((S,S)-(+)-5-{1-hydroxy-2-[1-methyl-2-(1-naphthyl)e...)
Affinity DataKi: >1.00E+8nMAssay Description:β1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBeta-1 adrenergic receptor(Mus musculus)
The Usa, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM50213104((S,S)-(+)-5-[1-hydroxy-2-(1-methyl-2-phenylethylam...)
Affinity DataKi: >1.00E+8nMAssay Description:β1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBeta-1 adrenergic receptor(Mus musculus)
The Usa, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM50213100((S,R)-(+)-5-[1-hydroxy-2-(1-methyl-2-phenylethylam...)
Affinity DataKi: >1.00E+8nMAssay Description:β1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBeta-1 adrenergic receptor(Mus musculus)
The Usa, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM50213102((S,S)-(+)-1-p-methoxyphenyl-2-(beta-3',5'-dihydrox...)
Affinity DataKi: >1.00E+8nMAssay Description:β1-AR binding was done on rat cortical membrane following a previously described procedure (Beer et al., Biochem. Pharmacol. 37: 1145-1151, 1988...More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 78 total ) | Next | Last >>
Jump to: